Newton P A
Postgrad Med. 1977 May;61(5):107-10. doi: 10.1080/00325481.1977.11712186.
The experience of a solo practitioner suggests that the incidence of multiple myeloma is higher than the widely reported figure of 2.7/100,000. Only by early recognition and treatment will the survival rate be increased. Measurement of the sedimentation rate may be helpful in spotting the disease, for a rapid rate in patients with bone pain and anemia suggests multiple myeloma.
一位个体执业医生的经验表明,多发性骨髓瘤的发病率高于广泛报道的每10万人中2.7例这一数字。只有通过早期识别和治疗才能提高生存率。血沉率的测量可能有助于发现该病,因为骨痛和贫血患者的血沉率较快提示多发性骨髓瘤。